These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28940329)

  • 21. FDA Approves First Treatment for Nonmetastatic, Castration-Resistant Prostate Cancer.
    Aschenbrenner DS
    Am J Nurs; 2018 Jun; 118(6):26. PubMed ID: 29794918
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer drugs remain FDA approved despite lack of benefit, study finds.
    McCarthy M
    BMJ; 2016 Dec; 355():i6568. PubMed ID: 27923801
    [No Abstract]   [Full Text] [Related]  

  • 23. Expediting the availability of drugs for US patients with cancer.
    Farrell AT; Pazdur R; von Eschenbach AC
    Nat Clin Pract Urol; 2008 Dec; 5(12):654-6. PubMed ID: 19050708
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulatory watch: Why do oncology drugs fail to gain US regulatory approval?
    Khozin S; Liu K; Jarow JP; Pazdur R
    Nat Rev Drug Discov; 2015 Jul; 14(7):450-1. PubMed ID: 26000722
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA approves regorafenib (Stivarga) for metastatic colorectal cancer.
    Oncology (Williston Park); 2012 Oct; 26(10):896. PubMed ID: 23175993
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA approves regorafenib (Stivarga) for GIST.
    Oncology (Williston Park); 2013 Mar; 27(3):164. PubMed ID: 23687782
    [No Abstract]   [Full Text] [Related]  

  • 27. Swimming upstream: an advocate reflects on cancer research and social realities.
    Mayer M
    J Clin Oncol; 2008 Jun; 26(16):2783-6. PubMed ID: 18509190
    [No Abstract]   [Full Text] [Related]  

  • 28. Many cancer drugs recently approved in US do not improve overall survival, study finds.
    McCarthy M
    BMJ; 2015 Oct; 351():h5634. PubMed ID: 26500344
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer drug approval in the United States, Europe, and Japan.
    Milsted RA
    Adv Cancer Res; 2007; 96():371-91. PubMed ID: 17161686
    [No Abstract]   [Full Text] [Related]  

  • 30. Hurry up and wait: is accelerated approval of new cancer drugs in the best interests of cancer patients?
    Schilsky RL
    J Clin Oncol; 2003 Oct; 21(20):3718-20. PubMed ID: 12963701
    [No Abstract]   [Full Text] [Related]  

  • 31. First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
    Lemery S; Keegan P; Pazdur R
    N Engl J Med; 2017 Oct; 377(15):1409-1412. PubMed ID: 29020592
    [No Abstract]   [Full Text] [Related]  

  • 32. The RACE to Develop New Targeted Therapies for Children With CNS Tumors.
    Fletcher EP; Burckart GJ; Robinson GW; Reaman GH; Stewart CF
    Clin Pharmacol Ther; 2020 Sep; 108(3):434-436. PubMed ID: 32638364
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeted agents: the rules of combination.
    Kwak EL; Clark JW; Chabner B
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5232-7. PubMed ID: 17875749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing.
    Vivot A; Boutron I; Béraud-Chaulet G; Zeitoun JD; Ravaud P; Porcher R
    Sci Rep; 2017 Jul; 7(1):6882. PubMed ID: 28761069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pioneering apoptosis-targeted cancer drug poised for FDA approval.
    Mullard A
    Nat Rev Drug Discov; 2016 Mar; 15(3):147-9. PubMed ID: 26931080
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA approves new drug for gastrointestinal stromal tumors.
    Clin J Oncol Nurs; 2002; 6(3):124. PubMed ID: 11998599
    [No Abstract]   [Full Text] [Related]  

  • 37. White House announces cancer-drug initiatives.
    Am J Health Syst Pharm; 1996 May; 53(10):1110. PubMed ID: 8734669
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA approves sorafenib for patients with inoperable liver cancer.
    Lang L
    Gastroenterology; 2008 Feb; 134(2):379. PubMed ID: 18242200
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug approval triggers debate on future direction for cancer treatments.
    Frantz S
    Nat Rev Drug Discov; 2006 Feb; 5(2):91. PubMed ID: 16521324
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA approves Gleevec for leukemia treatment.
    FDA Consum; 2001; 35(4):6. PubMed ID: 11692893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.